2-chlorodeoxyadenosine (2-CdA) in 2-hour versus 24-hour intravenous infusion in the treatment of patients with hairy cell leukemia

Leukemia and Lymphoma

Volumn 22, Issue 1-2, 1996, Pages 107-111

  Robak, T ^a   Blasinska Morawiec M ^a   Krykowski, E ^a   Hansz, J ^b   Komarnicki, M ^b   Kazimierczak, M ^b   Konopka, L ^c   Maj, S ^c   Hellmann, A ^d   Zaucha, J M ^d   Urasinski, L ^e   Zdziarska, B ^e   Kotlarek Haus, S ^f   Usnarska Zubkiewicz, L ^f   Kuratowska, Z ^g   Dwilewicz Trojaczek, J ^g   Holowiecki J ^h   Krawczyk Kulis M ^h   Grieb, P ⁱ  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^d MEDICAL UNIVERSITY OF GDANSK   (Poland)

^e POMERANIAN MEDICAL UNIVERSITY   (Poland)

^f Academy of Medicine   (Poland)

^g MEDICAL UNIVERSITY OF WARSAW   (Poland)

^h MEDICAL UNIVERSITY OF SILESIA   (Poland)

ⁱ MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

2 chlorodeoxyadenosine; Efficiency; Hairy cell leukemia; Side effects

Indexed keywords

CLADRIBINE;

ARTICLE; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; ECZEMA; FEVER; GASTROINTESTINAL SYMPTOM; HAIRY CELL LEUKEMIA; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; JAUNDICE; LEUKEMIA REMISSION; LYMPHOCYTOPENIA; NEUTROPENIA; PRIORITY JOURNAL; PRURITUS; THROMBOCYTOPENIA;

EID: 15844406220     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609051736     Document Type: Article

References (23)

1. Bouroncle, A. B., Wiseman, B. K., Doan, C. A. (1958) Leukemic reticuloendotheliosis. Blood, 13, 609-630.
2. Catovsky, D., Foa, R. (1990) The Lymphoid Leukaemias pp. 156-181. London Butterworths.
3. Chang, K. L., Stroup, R., Weiss, L. M. (1992) Hairy cell leukemia - Current Status. Am. J. Clin. Pathol. 97, 719-738.
4. Saven, A. and Piro, L. D. (1992) Treatment of hairy cell leukemia. Blood 79, 111-1120.
5. Golomb, H. M. (1987) The treatment of hairy cell leukemia. Blood 69, 979-983.
6. Smalley, R. V., Connors, J., Tuttle, R. L., Anderson, S., Robinson, W., Whismant, J. K. (1992) Splenectomy vs alpha interferon in previously untreated hairy cell leukemia. Am. J. Haematol 41, 13-18.
7. Quesada, J. R., Reuben, J., Mauning, J. T., Hersh, E. M. and Gutterman, J. U. (1984) Alpha interferon for induction of remission in hairy cell leukemia. N. Engl. J. Med. 310, 15-18.
8. Lill, M. C. C. and Golde, D. W. (1990) Treatment of hairy cell leukemia. Blood Rev. 4, 238-444.
9. Smith, II J. W., Longo, D. L., Urba, W. J., Clark, J. W., Watson, I., Baveridge, J., Canion, K. C., Szmol, M., Creemore, S. P., Alvord, W. G., Lawrence, J. B. and Steis, R. G. (1991) Prolonged continous treatment of hairy cell leukemia patients with recombinant interferon alpha. N. Engl. J. Med. 78, 1664-1671.
10. Cassileth, P. A., Cheuvant, B., Spiers, A. S. D., Harrington, D. P., Cummings, F. J., Neiman, R. S., Bennett, J. M., O'Counell, M. J. (1991) Pentostatin induces durable remissions in hairy cell leukemia. J. Clin. Oncol. 9, 243-246.
11. Piro, L. D., Carrera, C. J., Carson, D. L. and Beutler, E. (1990) Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. N. Engl. J. Med. 322, 1117-1121.
12. Saven, A. and Piro, L. D. (1993) 2-chlorodeoxyadenosine in the treatment of hairy cell leukemia and chronic lymphocytic leukemia. Leuk. Lymph. 11 (suppl. 2), 109-114.
13. Estey, E. M., Kurzrock, R., Kantarjian, H. M., O'Brian, S., Mc Credie, K., Baran, M., Koller, C., Keating, M., Hirsch-Ginsberg, C., Huy, Y. O., Stass, S., and Freireich, E. (1992) Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine (2-CdA). Blood, 79, 882-887.
14. Saven, A. and Piro, L. D. (1994) The newer purine analogues for the treatment of hairy-cell leukemia. New Engl. J. Med. 330, 691-697.
15. Juliusson, G., Liliemark, J. (1993) High complete remission rate from 2-chloro-2′-deoxyadenosine in previously treated patients with B-cell chronic lymphocytic leukemia: Response predicted by rapid decrease of blood lymphocyte count. J. Clin. Oncol. 11, 679-689.
16. Liliemark, J., Pettersson, B., Juliusson, G. (1991) The relationship between plasma 2-chloro- 2′-deoxyadenosine (CdA) and cellular CdA nucleotides (CdAN) after intermittent and continuous I.V. infusion in patients with chronic lymphocytic leukemia. Blood, 78, 269a (suppl. 1, abstract).
17. Cordell, J. L., Falini, B., Erber, W. N., Ghosh, A. K., Abdullaziz, Z., Macdonald, S., Pulford, K. A. F., Stein, H., Mason, D. Y. (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J. Histochem. Cytochem. 52, 219-231.
18. Kazimierczuk, Z., Vilpo, J., Hildebrand, C., Wright, G. (1990) Synthesis and cytotoxicity of deoxyadenosine analogues: isomer distribution in the sodium salt glycosylation of 2,6-disubstituted purines. J. Med. Chem. 33, 1683-1687.
19. Spiers, A. S. D., Moore, D., Cassileth, P., Harrington, D. P., Cummings, F. J., Neiman, R. S., Bennett, J. M., O'Connel, M. J. (1987) Remissions in hairy-cell leukemia with pentostatin (2′-deoxycoformycin). N. Engl. J. Med 316, 825-830.
20. Juliusson, G., and Liliemark, J. (1992) Rapid recovering from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′-deoxyadenosine (CdA): Relation to opportunistic infection. Blood 79, 888-894.
21. Hakimian, D., Tallman, M. S., Kiley, C., Peterson, L. A. (1993) Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Blood. 82, 1798-1802.
22. Filleul, B., Delannoy, A., Ferrant, A., Zenebergh, S., Van Daele, S., Body, A., Doyen, C., Mineur, P., Glorieux, P., Driesschaert, P., Sokal, G., Martiat, P., Michaux, J. L. (1994) A single course of 2-chlorodeoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission. Leukemia 8, 1153-1156.
23. Polliack, A., Dann, E. J. (1994) Rapid massive splenic relapse of hairy cell leukemia (HCL) during bone marrow remission after 2-chlorodeoxyadenosine therapy: the spleen as a sanctuary site in HCL. Blood. 83, 2 057-2058.